Kibrom Hadera Teklehaimanot

Kibrom Teklehaimanot practices at MultiCare Good Samaritan Hospital in Puyallup, Washington, part of MultiCare Health System.

Kibrom Teklehaimanot's NPI, 1669963211, was assigned on May 18, 2018. Kibrom Teklehaimanot holds Washington license MD61137242.

Kibrom Teklehaimanot's primary practice is MultiCare Good Samaritan Hospital, at 401 15th Avenue SE, Puyallup, WA 98372 in Pierce County. The practice phone is (253) 697-2102.

Kibrom Teklehaimanot's primary practice is MultiCare Good Samaritan Hospital in Puyallup, Washington, part of MultiCare Health System. Kibrom Teklehaimanot is also affiliated with MultiCare Tacoma General Hospital. The medical group on file is Sound Physicians. Dmand AI also links Kibrom Teklehaimanot to 1 more hospital, 2 medical groups, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kibrom Teklehaimanot practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Kibrom Teklehaimanot's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Kibrom Teklehaimanot is licensed in Washington.

CMS data shows 1,096 Medicare services from Kibrom Teklehaimanot across 6 procedure codes in 2024, for 379 Medicare patients. Medicare paid $90,474 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 379 Medicare patients who saw Kibrom Teklehaimanot in 2024. The largest group is 75 to 84, with 144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kibrom Teklehaimanot's median patient age at 75, with 51% women.

In 2024, Kibrom Teklehaimanot wrote 510 Medicare Part D claims for 217 patients. 89% of them were for generic drugs. CMS names the drug for 217 of them, across 10 drugs with 11 or more claims each, at $1,969 in total drug cost. In 2023, CMS named 200 claims across 11 drugs.

Kibrom Teklehaimanot accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 20 general payments to Kibrom Teklehaimanot from 9 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $270.